Lineage Cell Therapeutics (LCTX) Debt to Equity (2014 - 2021)

Lineage Cell Therapeutics (LCTX) reported Debt to Equity of $0.0 for Q1 2021, down 18.39% quarter-over-quarter from $0.01 in Q4 2020.

Lineage Cell Therapeutics (LCTX) Debt to Equity (2014 - 2021) Analysis & Trends

Lineage Cell Therapeutics has reported Debt to Equity for 6 years, with the latest figure at $0.0 in Q1 2021.

  • For the quarter ending Q1 2021, Debt to Equity changed N/A year-over-year to $0.0; the trailing twelve-month figure through Mar 2021 stood at $0.0 (changed N/A YoY), and the FY2020 full-year result was $0.01, changed N/A from the prior year.
  • Debt to Equity for Q1 2021 stood at $0.0, down from $0.01 in the prior quarter.
  • The five-year high for Debt to Equity was $0.01 in Q3 2020, with the low at $0.0 in Q4 2017.
  • Historically, Debt to Equity has averaged $0.0 across 3 years, with a median of $0.0 in 2021.
  • The largest YoY upside for Debt to Equity was 73.27% in 2017 against a maximum downside of 88.08% in 2017.
  • Lineage Cell Therapeutics' Debt to Equity stood at $0.0 in 2017, then jumped by 4917.24% to $0.01 in 2020, then fell by 18.39% to $0.0 in 2021.
  • The last three Debt to Equity figures came in at $0.0 (Q1 2021), $0.01 (Q4 2020), and $0.01 (Q3 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Lineage Cell Therapeutics 303.84 Mn 239.94 Mn 1.73 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 0.00
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.01
Dec 31, 2017 0.00
Sep 30, 2017 0.00
Jun 30, 2017 0.00
Mar 31, 2017 0.00
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Jun 30, 2016 0.00
Mar 31, 2016 0.00
Dec 31, 2015 0.00
Sep 30, 2015 0.00
Jun 30, 2015 0.00
Mar 31, 2015 0.00
Dec 31, 2014 0.00
Sep 30, 2014 0.00
Jun 30, 2014 0.00